BACKGROUND: A rise or fall of cardiac troponin is a prerequisite for the diagnosis of acute myocardial infarction. Defining significant changes requires knowledge of both biological and analytical variation. The short-term biological variation of cardiac troponin in healthy individuals is 3%-48%. However, healthy individuals may not be representative for patients in whom cardiac troponin measurement is often of clinical importance. Therefore, we studied the individual variation of cardiac troponin in patients with symptoms of stable coronary artery disease. METHODS: Twenty-four patients scheduled for elective coronary angiography were included. Blood samples were drawn once at enrollment and serially at six 4-h intervals on the day before coronary angiography. Cardiac troponin was measured with hs-cTn assays from Abbott Laboratories (premarket cTnI assay) and Roche Diagnostics (Elecsys(®) cTnT assay with two different lots). RESULTS: The short-term individual variation in cardiac troponin I (cTnI) was 14%, the reference change value (RCV) 49%, and RCV-log-normal (rise/fall) 54%/-35%. The corresponding values for cTnT were 7%, 23%, and 26%/-21%. The long-term variation for cTnI was 24%, RCV 69%, and RCV-log-normal (rise/fall) 97%/-49%. The corresponding values for cTnT were 11%, 32%, and 37%/-27%. CONCLUSIONS: The short-term individual variation of cardiac troponin in patients with symptoms of stable coronary artery disease is similar to the biological variation previously demonstrated in healthy individuals. Our results suggest that a change in cardiac troponin concentrations of >50% can be used in attempting to diagnose acute myocardial injury. To detect significant long-term changes in cardiac troponin concentrations, larger changes will be required.
BACKGROUND: A rise or fall of cardiac troponin is a prerequisite for the diagnosis of acute myocardial infarction. Defining significant changes requires knowledge of both biological and analytical variation. The short-term biological variation of cardiac troponin in healthy individuals is 3%-48%. However, healthy individuals may not be representative for patients in whom cardiac troponin measurement is often of clinical importance. Therefore, we studied the individual variation of cardiac troponin in patients with symptoms of stable coronary artery disease. METHODS: Twenty-four patients scheduled for elective coronary angiography were included. Blood samples were drawn once at enrollment and serially at six 4-h intervals on the day before coronary angiography. Cardiac troponin was measured with hs-cTn assays from Abbott Laboratories (premarket cTnI assay) and Roche Diagnostics (Elecsys(®) cTnT assay with two different lots). RESULTS: The short-term individual variation in cardiac troponin I (cTnI) was 14%, the reference change value (RCV) 49%, and RCV-log-normal (rise/fall) 54%/-35%. The corresponding values for cTnT were 7%, 23%, and 26%/-21%. The long-term variation for cTnI was 24%, RCV 69%, and RCV-log-normal (rise/fall) 97%/-49%. The corresponding values for cTnT were 11%, 32%, and 37%/-27%. CONCLUSIONS: The short-term individual variation of cardiac troponin in patients with symptoms of stable coronary artery disease is similar to the biological variation previously demonstrated in healthy individuals. Our results suggest that a change in cardiac troponin concentrations of >50% can be used in attempting to diagnose acute myocardial injury. To detect significant long-term changes in cardiac troponin concentrations, larger changes will be required.
Authors: Michael Kopec; Andreas Duma; Mohammad A Helwani; Jamie Brown; Frank Brown; Brian F Gage; David W Gibson; J Philip Miller; Eric Novak; Allan S Jaffe; Fred S Apple; Mitchell G Scott; Peter Nagele Journal: Anesth Analg Date: 2017-02 Impact factor: 5.108
Authors: Alessandra Barassi; Raffaele Pezzilli; Antonio Maria Morselli-Labate; Elena Dozio; Luca Massaccesi; Francesca Ghilardi; Clara Anna Linda Damele; Giovanni Maria Colpi; Gian Vico Melzi d'Eril; Massimiliano Marco Corsi Romanelli Journal: Dis Markers Date: 2015-04-16 Impact factor: 3.434
Authors: Peter Willeit; Paul Welsh; Jonathan D W Evans; Lena Tschiderer; Charles Boachie; J Wouter Jukema; Ian Ford; Stella Trompet; David J Stott; Patricia M Kearney; Simon P Mooijaart; Stefan Kiechl; Emanuele Di Angelantonio; Naveed Sattar Journal: J Am Coll Cardiol Date: 2017-08-01 Impact factor: 24.094
Authors: Ziad Hijazi; Bertil Lindahl; Jonas Oldgren; Ulrika Andersson; Johan Lindbäck; Christopher B Granger; John H Alexander; Bernard J Gersh; Michael Hanna; Veli-Pekka Harjola; Elaine M Hylek; Renato D Lopes; Agneta Siegbahn; Lars Wallentin Journal: J Am Heart Assoc Date: 2017-06-23 Impact factor: 5.501
Authors: Anna M Nordenskjöld; Per Hammar; Håkan Ahlström; Tomas Bjerner; Olov Duvernoy; Bertil Lindahl Journal: PLoS One Date: 2018-07-06 Impact factor: 3.240
Authors: Anna M Nordenskjöld; Per Hammar; Håkan Ahlström; Tomas Bjerner; Olov Duvernoy; Kai M Eggers; Ole Fröbert; Nermin Hadziosmanovic; Bertil Lindahl Journal: PLoS One Date: 2016-02-17 Impact factor: 3.240
Authors: Graham R Lee; Tara Ca Browne; Berna Guest; Imran Khan; Eamon Murphy; Catherine McGorrian; Niall G Mahon; Maria C Fitzgibbon Journal: Pract Lab Med Date: 2016-01-13